Health products
Our expertise
Magenta has unique expertise in competition law and sector-specific regulations, particularly in the healthcare products and regulated distribution channels sector.
The healthcare products sector (including medicinal products for human and veterinary use, medical devices and cosmetics) faces significant competitive constraints resulting from constant economic and financial regulation.
Magenta supports leading players in the pharmaceutical and medical device industry with their relationships with distributors and competitors. Magenta has developed a practice focusing on access to the healthcare product market, advising clients on how to prepare and negotiate their pricing and reimbursement applications with health authorities.
Our work
Assisting pharmaceutical laboratories in drawing up and implementing commercial and pricing strategies in anticipation of the launch of generic medicines.
Assisting and representing pharmaceutical laboratories in litigation against decisions made by the French Economic Committee for Health Products (CEPS), such as pricing and refused price increases.
Assisting with the preparation and negotiation of pricing and reimbursement applications for medicines and medical devices (standard market access process and exemptions, add-on list).
Assisting pharmaceutical laboratories in defining and implementing contingency practices and supply quotas.
Helping manufacturers with the development of relations with healthcare professionals in compliance with the no-gift policy.
Assisting pharmaceutical and medical device laboratories in defining and implementing their commercial distribution policies for reimbursed and OTC products.
Assisting a cosmetic laboratory in defining and implementing its commercial policy in specialised channels via a selective distribution network.
Assisting pharmaceutical and medical device manufacturers with the tendering process for supplying products to public healthcare institutions.
Our rankings
